medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2019, Number 1

<< Back Next >>

Arch Med Fam 2019; 21 (1)

Myths About Insulin in Patients with Type 2 Diabetes Evaluated at the Central Hospital of the Peruvian Air Force

Lizarzaburu Robles Juan-Carlos, Vento CF, Torres AH, Zelada CH, Laca FJ, Rivera VK, Valera CJ

Language: Spanish
References: 26
Page: 19-27
PDF size: 210.38 Kb.


ABSTRACT

Objective:To describe and discuss the myths regarding insulin therapy in patients with type 2 diabetes in a general hospital in Lima-Peru. Methods: A cross-sectional study included 360 patients with type 2 diabetes who attended an outpatient endocrinology clinic at the Central Air-Force Hospital in Lima-Peru. The frequency of myths about insulin therapy using a questionnaire with a Likert scale was evaluated. We describe and analyze every myth and evaluate those regarding Insulin users (IU) and patients who received education about the use of this medication. Results: Of a total of patients, 60.8% were women, 37.2% were insulin users (IU), the mean age was 67.4±10.7 years and the mean of disease duration was 10.3±9.2 years. Among Insulin Users, 66% had received education in insulin therapy. “Once people begin using insulin, they will have to take it for the rest of their life” was the most frequent myth (48%), while “Insulin shots are painful” was the lowest (13.9%). The presence of myths was high in NUI. The frequency of myths among those who received education on the use of insulin was not significantly lower. Conclusion:The Myths evaluated were present with different frequencies, higher in NIU. Education in insulin therapy was not a condition to reduce the presences of myth.


REFERENCES

  1. Seclen SN, Rosas ME, Arias AJ, et al. Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study. BMJ Open Diabetes Research and Care. 2015 Jan; 3:1-7.

  2. Villena JE. Diabetes Mellitus in Peru. Ann Glob Health. 2015 Nov-Dec; 81(6): 765–775.

  3. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med. 2013 april;368:1613–24

  4. Stone MA, Charpentier G, Doggen K, Kuss O, Lindblad U, Kellner C, Nolan J, Pazderska A, Rutten G, Trento M, Khunti K; GUIDANCE Study Group. Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care. 2013 Sep;36(9):2628-2638

  5. Owens DR. Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes. Diabetes technology & therapeutics. 2013;15(9):776-85.

  6. American Diabetes Association. Approaches to Glycemic Treatment. Diabetes Care. 2016 Jan ;39 (Supplement 1):S52–59.

  7. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2017 Executive Summary. Endocr Pract. 2017 Feb;23(2):207-238.

  8. Abu Hassan H, Tohid H, Mohd Amin R, Long Bidin MB, Muthupalaniappen L, Omar K. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Fam Pract. 2013;14:164.

  9. Wallia A, Molitch ME. Insulin therapy for type 2 diabetes mellitus. JAMA. 2014 Jun;311(22):2315–2325.

  10. Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med J Br Diabet Assoc. 2007 Dec;24(12):1412-18.

  11. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 Oct;28(10):2543–45.

  12. Insulin Myths and Facts: Clinical Diabetes 2007 jan;25 (1): 39-40

  13. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger P-M. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med. 2012 May;29(5):682–89.

  14. Gutiérrez RR, Ferro AM, Caballero AE. Myths and Misconceptions about Insulin Therapy among Latinos/Hispanics with Diabetes: A Fresh Look at an Old Problem. J Diabetes Metab. 2015 jan. 6:482.

  15. Devin M. Mann, Diego Poneiman, Howard Leventhal, Ethan A. Halm. Misconceptions About Diabetes and its Management Among Low-income Minorities with Diabetes. Diabetes Care. 2009 Apr; 32(4): 591–593.

  16. Rai M, Kishore J. Myths about diabetes and its treatment in North Indian population. International Journal of Diabetes in Developing Countries. 2009 july;29(3):129-132.

  17. Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ. 2006 Feb;32(1 Suppl):9S–18S.

  18. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–307.

  19. Casciano R, Malangone E, Ramachandran A, Gagliardino J. A quantitative assessment of patient barriers to insulin. Int J Clin Pract. 2011 Apr;65(4):408-14.

  20. Lerman I. Barreras que dificultan la aplicación temprana de insulina en el paciente con diabetes tipo 2. Asociación Latinoamericana de Diabetes. VOL. XVII-N° 2- Ańo 2009

  21. Brod M, Kongsř JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2009 Feb;18(1):23–32.

  22. Hu J, Amirehsani KA, Wallace DC, Letvak S. The meaning of insulin to Hispanic immigrants with type 2 diabetes and their families. Diabetes Educ. 2012 Apr;38(2):263–70.

  23. Hasliza Abu Hassan, Hizlinda TohidEmail author, Rahmah Mohd Amin, Mohamed Badrulnizam Long Bidin, Leelavathi Muthupalaniappen and Khairani Omar. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Family Practice 2013 Oct;14:164.

  24. Polinski JM, Curtis BH, Seeger JD, Choudhry NK, Zagar A, Shrank WH. Rationale and design of the multinational observational study assessing insulin use: The MOSAIc study. BMC Endocrine Disorders 2012 Sep 12:20.

  25. Allen NA, Zagarins SE, Feinberg RG, Welch G. Treating psychological insulin resistance in type 2 diabetes. J Clin Transl Endocrinol. 2016 Nov 30;7:1-6

  26. Poss JE1, Jezewski MA, Stuart AG. Home remedies for type 2 diabetes used by Mexican Americans in El Paso, Texas. Clin Nurs Res. 2003 Nov;12(4):304-23.




2020     |     www.medigraphic.com